rs761316361

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2

The NM_014491.4(FOXP2):​c.495_506delACAACAGCAGCA​(p.Gln166_Gln169del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000844 in 1,611,874 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000080 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000085 ( 0 hom. )

Consequence

FOXP2
NM_014491.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 5.77

Publications

0 publications found
Variant links:
Genes affected
FOXP2 (HGNC:13875): (forkhead box P2) This gene encodes a member of the forkhead/winged-helix (FOX) family of transcription factors. It is expressed in fetal and adult brain as well as in several other organs such as the lung and gut. The protein product contains a FOX DNA-binding domain and a large polyglutamine tract and is an evolutionarily conserved transcription factor, which may bind directly to approximately 300 to 400 gene promoters in the human genome to regulate the expression of a variety of genes. This gene is required for proper development of speech and language regions of the brain during embryogenesis, and may be involved in a variety of biological pathways and cascades that may ultimately influence language development. Mutations in this gene cause speech-language disorder 1 (SPCH1), also known as autosomal dominant speech and language disorder with orofacial dyspraxia. Multiple alternative transcripts encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
FOXP2 Gene-Disease associations (from GenCC):
  • specific language disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood apraxia of speech
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_014491.4
BP6
Variant 7-114629882-GCAGCAGCAACAA-G is Benign according to our data. Variant chr7-114629882-GCAGCAGCAACAA-G is described in ClinVar as Likely_benign. ClinVar VariationId is 1744328.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXP2NM_014491.4 linkc.495_506delACAACAGCAGCA p.Gln166_Gln169del disruptive_inframe_deletion Exon 5 of 17 ENST00000350908.9 NP_055306.1 O15409-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXP2ENST00000350908.9 linkc.495_506delACAACAGCAGCA p.Gln166_Gln169del disruptive_inframe_deletion Exon 5 of 17 1 NM_014491.4 ENSP00000265436.7 O15409-1

Frequencies

GnomAD3 genomes
AF:
0.0000797
AC:
12
AN:
150636
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000488
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000212
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000133
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000847
AC:
21
AN:
247926
AF XY:
0.0000968
show subpopulations
Gnomad AFR exome
AF:
0.000186
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.000108
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000849
AC:
124
AN:
1461120
Hom.:
0
AF XY:
0.0000881
AC XY:
64
AN XY:
726848
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33472
American (AMR)
AF:
0.0000895
AC:
4
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39626
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86112
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53294
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000953
AC:
106
AN:
1111718
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000796
AC:
12
AN:
150754
Hom.:
0
Cov.:
33
AF XY:
0.0000544
AC XY:
4
AN XY:
73588
show subpopulations
African (AFR)
AF:
0.0000487
AC:
2
AN:
41066
American (AMR)
AF:
0.00
AC:
0
AN:
15104
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5068
South Asian (SAS)
AF:
0.000212
AC:
1
AN:
4718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000133
AC:
9
AN:
67570
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000158
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Sep 10, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.8
Mutation Taster
=117/83
disease causing (fs/PTC)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761316361; hg19: chr7-114269937; COSMIC: COSV63484297; COSMIC: COSV63484297; API